1. Home
  2. PPCB vs BNGO Comparison

PPCB vs BNGO Comparison

Compare PPCB & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPCB
  • BNGO
  • Stock Information
  • Founded
  • PPCB 2007
  • BNGO 2003
  • Country
  • PPCB Australia
  • BNGO United States
  • Employees
  • PPCB N/A
  • BNGO N/A
  • Industry
  • PPCB
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PPCB
  • BNGO Industrials
  • Exchange
  • PPCB Nasdaq
  • BNGO Nasdaq
  • Market Cap
  • PPCB 20.4M
  • BNGO 24.3M
  • IPO Year
  • PPCB N/A
  • BNGO 2018
  • Fundamental
  • Price
  • PPCB $1.26
  • BNGO $1.82
  • Analyst Decision
  • PPCB
  • BNGO Buy
  • Analyst Count
  • PPCB 0
  • BNGO 4
  • Target Price
  • PPCB N/A
  • BNGO $7.67
  • AVG Volume (30 Days)
  • PPCB 337.6K
  • BNGO 522.3K
  • Earning Date
  • PPCB 09-30-2025
  • BNGO 11-14-2025
  • Dividend Yield
  • PPCB N/A
  • BNGO N/A
  • EPS Growth
  • PPCB N/A
  • BNGO N/A
  • EPS
  • PPCB N/A
  • BNGO N/A
  • Revenue
  • PPCB N/A
  • BNGO $27,426,000.00
  • Revenue This Year
  • PPCB N/A
  • BNGO N/A
  • Revenue Next Year
  • PPCB N/A
  • BNGO $24.54
  • P/E Ratio
  • PPCB N/A
  • BNGO N/A
  • Revenue Growth
  • PPCB N/A
  • BNGO N/A
  • 52 Week Low
  • PPCB $1.25
  • BNGO $1.50
  • 52 Week High
  • PPCB $145.46
  • BNGO $22.80
  • Technical
  • Relative Strength Index (RSI)
  • PPCB N/A
  • BNGO 38.66
  • Support Level
  • PPCB N/A
  • BNGO $1.81
  • Resistance Level
  • PPCB N/A
  • BNGO $1.97
  • Average True Range (ATR)
  • PPCB 0.00
  • BNGO 0.09
  • MACD
  • PPCB 0.00
  • BNGO 0.03
  • Stochastic Oscillator
  • PPCB 0.00
  • BNGO 5.71

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: